Oxandrolone Tablets, USP, 10 mg, Rx Only, C-III, 60-count bottle, Manufactured for: Upsher-Smith ...
FDA Drug Recall #D-1255-2014 — Class III — April 14, 2014
Recall Summary
| Recall Number | D-1255-2014 |
| Classification | Class III — Low risk |
| Date Initiated | April 14, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Upsher Smith Laboratories, Inc. |
| Location | Maple Grove, MN |
| Product Type | Drugs |
| Quantity | 1,185 bottles |
Product Description
Oxandrolone Tablets, USP, 10 mg, Rx Only, C-III, 60-count bottle, Manufactured for: Upsher-Smith Labs, Minneapolis, MN 55447, by: Pharmaceutics International, Inc., Hunt Valley, MD 21031, NDC 0245-0272-06
Reason for Recall
Labeling: Missing Label; Three cases of product (total of 36 bottles) were packaged without the primary label on the bottle. The cases were, however, packaged in the correct finished product shipper, labeled with the correct shipper bar code label, sealed with tamper-evident tape and erroneously shipped to Upsher-Smith.
Distribution Pattern
Nationwide
Lot / Code Information
Lot #2802.042A, Exp. 10/2015
Other Recalls from Upsher Smith Laboratories, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1836-2019 | Class II | Bexarotene Capsules, 75 mg, 100 capsules per bo... | Jul 29, 2019 |
| D-0281-2019 | Class II | Bumetanide Tablets, USP, 2 mg, 100-count bottle... | Sep 19, 2018 |
| D-0280-2019 | Class II | Bumetanide Tablets, USP, 1 mg, 100-count bottle... | Sep 19, 2018 |
| D-127-2013 | Class III | Divalproex Sodium Delayed-Release Tablets, USP,... | Dec 10, 2012 |
| D-160-2013 | Class II | Propranolol Hydrochloride Extended-release Caps... | Nov 20, 2012 |
Frequently Asked Questions
Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.